President

Selection Panel

All companies joining the Tech Tour AI for Health 2024 programme will be selected by the Selection Panel. This Selection Panel is responsible for nominating companies and will select the best 40 companies to take part in the programme. 

Roberto Ascione

President, Health Innovation

EVERSANA (United States)

prevention

Pedro Castel-Branco

Armilar Venture Partners (Portugal)

Tony Chang

Senior Business Developer

BioInnovation Institute (Denmark)

Marina Du

Associate Investor

Hitachi Ventures (Germany)

Steven Everaert

kineo finance AG (Switzerland)

prevention

Raphael Faessler

Investment Director

Swiss Post Ventures (Switzerland)

Alper Karagoz

Partner

Diffusion Capital Partners (DCP) (Turkiye)

Lauri Kuronen

Key Account Manager

LKP-Invest (Finland)

Virtual care

Ari-Pekka Laitsaari

Growth Capital and Innovation Finance

European Investment Bank (Luxembourg)

prevention

Steven Leuridan

Partner

Qbic (Belgium)

Erki Mölder

Managing Partner

Health Founders (Estonia)

Virtual care

prevention

Kreske Nickelsen

Partner

DiaMedCare (Switzerland)

Nicolas Olberg

IT Investor & Managing Director

Twip Impact Ventures (Germany)

Kustaa Piha

CEO and Investor in Healthcare and Medtech

Athensmed Oy (Finland)

Dietmar Schlößer

Director Digitalization & Innovation

TÜV NORD GROUP (Germany)

Tim Schneider

Investment Associate

MTIP (Switzerland)

Remi Spagnol

Investments Healthcare

Supernova Invest (France)

Sophia Tran

Founder & CEO

Spotlight! Ventures (Germany)

James Wilson

Senior Analyst

Silverpeak (United Kingdom)